Skip to main content
Premium Trial:

Request an Annual Quote

RNAi Global Initiative to Solicit Additional Input from Non-Members

NEW YORK, Dec. 7 (GenomeWeb News) - At the first meeting of the Genome-Wide RNAi Global Initiative, the member institutions agreed to "solicit additional input from other external sources," Dharmacon, the group's leader, said today.

 

The group, formed in October, is an alliance of Dharmacon and 10 international research centers pioneering whole-genome RNAi screening.

 

At the meeting, participants shared best practices and discussed collaborations to accelerate biomedical discovery using the genome-wide library, Dharmacon said.

 

The initiative plans to meet twice a year.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.